Sopino, Vicente C.
HRN: 11-26-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/08/2022
11/15/2022
IV
600mg
Q8
Infected Would L Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes